Learning Objectives: 

1. Name at least one type of health effect of wildfire smoke that has been well-documented in children.
2. Name at least one potential mitigation strategy for prevention of wildfire smoke health effects in children.
3. Discuss issues involved in school decision-making regarding wildfire smoke exposure.

 Moderator: Scott Needle, MD, FAAP 

 

Scott Needle, MD, FAAP Chief Medical Officer/Pediatrician

Elica Health Centers (Sacramento CA)

AAP Council on Children & Disasters Executive Committee 

 

Presenter: Stephanie Holm, MD, MPH

Learning Objectives:

• Describe two key mechanisms of neurological effects of air pollution
• Identify air pollutants that have been associated with neurodevelopmental effects
• Describe policy options to reduce air pollution exposure

Melanie Marty, PhD
Assistant Deputy Director
Office of Environmental Health Hazard Assessment
California EPA
PEHSU Region 9

Learning Objectives:

• To identify one state health department’s approach to wildfire smoke response
• To describe risk communication for wildfire smoke response and challenges of competing risks
• To evaluate a risk assessment approach to provide health justification to public decisions

Presenter: Julie Fox, PhD, MHS

Learning Objectives

• Identify scope of wildfires in the U.S. and identify interagency resources available.
• Describe health impacts of wildfires and identify populations of concern.
• Learn risk communication strategies to address wildfire smoke for health professionals.

Learning Objectives

Presented By:

Jennifer Lowry, MD, FACMT

Chief, Section of Clinical Toxicology

Medical Director, Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation

Children's Mercy Kansas City

Region 7 PEHSU

 

• Describe how people can be exposed to arsenic
• Evaluate the epidemiological evidence linking in utero and early life exposures to adverse pregnancy outcomes and children's health
• Recommend ways to reduce exposure to arsenic

Presented By:

 

At the conclusion of this activity, attendees should be able to:

The speaker will begin by presenting several clinical cases/case presentations. The cases to be presented will be provided in final proposal. This will be followed by a discussion of the outcome of the case with consideration and implications for current and future clinical and public health practice. The presenter will conclude by discussing preventive steps that can be taken to decrease exposure to environmental hazards and improve patient care.

Case discussed:

The parents of a 6-year old boy with learning and motor delays present to the child’s primary care provider. There have been no recent changes, and vital signs are normal. A developmentally delayed cousin was recently “tested for heavy metals”, so the parents request that these labs be checked for their child as well. In addition to basic labs, heavy metal blood and urine tests are ordered. All results are WNL, except for a random urine arsenic of 93 mcg/gm Cr.

Presented by:

Learning Objectives:

• Understand the value health navigators can bring to clinical programs and how they can and do interact with clinicians
• State some of the effects on outcomes experienced with navigator-based programs and specific cost-avoidance seen with a home visit program for children with asthma

Mark Anderson, MD, FAAP

Physician, Kid’s Care Clinic, Denver Health Medical Center

Associate Professor of Pediatrics, University of Colorado

Denver, CO

Principal Investigator, PEHSU Region 8

By the end of this webinar, participants should be able to:

Presenter: Susan Buchanan, MD, MPH

• Be able to describe risk and trends for children of Hispanic background relative to white children.
• Clinicians will be able to identify several environmental exposures associated with increased risk for leukemia.
• Be able to describe two factors associated with reduced risk for development of childhood leukemia.

Mark Miller, MD, MPH

 

Learning Objectives:

• List signs and symptoms associated with inhalational mercury toxicity
• Discuss challenges in the management of mercury toxicity
• Describe cleanup of household elemental mercury contamination

Learning Objectives:

• Describe danger of improper phosphide application in community
• Identify vulnerable age group and why
• Describe PPE required for providers
• Describe manifestations of PH3 poisoning
• Describe treatment of PH3 poisoning
• Describe challenges in declaring exposure site safe for reoccupancy

Thomas G. Martin, MD, MPH, FACMT, FAACT, FACEP
NW Texas Healthcare System
Medical Director Texas Panhandle Poison Center
Consultant - Med Tox Consults, PLLC
Amarillo, Tx
Region 6

 

 

Learning Objectives

• Understand the activity of the PEHSU as it pertains to lead poisoning surveillance in Region 7
• Discuss controversies in management when uncommon sources are found to cause elevated lead levels in children
• Recognize unintended consequences from acute exposures to environmental toxins such as mercury

Jennifer Lowry, MD, FACMT
Medical Director, Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation
University of Washington
Children's Mercy Kansas City
Kansas City, MO

Region 7 PEHSU

 

Learning Objectives

At the conclusion of this activity, attendees should be able to:

The speaker will begin by presenting several clinical cases/case presentations. The cases to be presented will be provided in final proposal. This will be followed by a discussion of the outcome of the case with consideration and implications for current and future clinical and public health practice. The presenter will conclude by discussing preventive steps that can be taken to decrease exposure to environmental hazards and improve patient care.

Cyrus Rangan, MD, FAAP, FACMT
Director, Bureau of Toxicology and Environmental Assessment
Los Angeles County Department of Public Health
Los Angeles, CA

Region 9 PEHSU

 

At the conclusion of this activity, attendees should be able to:

The presenter will begin by describing the study methodologies used in the journal articles to be discussed. This will be followed by a discussion of the results of the studies under consideration and implications for current clinical and public health practice. The presenter will conclude by discussing preventive steps that can be taken to decrease exposure in the journal articles.

Articles discussed:

1. Intentional and Inadvertent Chemical Contamination of Food, Water, and Medication
MCKay C and Scharman EJ 
Emergency Medicine Clinics of North America 2015; 33(1): 153-177

2. Incidence of waterborne lead in private drinking water systems in Virginia
Pieper KJ, Krometis LH, Gallagher DL, Banham BL, and Edwards M
Journal of Water and Health 2015; 13(3): 897-908

3. Elevated Blood Lead Levels in Children Associated with the Flint Drinking Water Crisis: A Spatial Analysis of Risk and Public Health Response
Hanna-Attisha M, LaChance J, Sadler RCS, and Schnepp AC 
American Journal of Public Health 2016; 106(2): 283-290

Presented by:

At the conclusion of this activity, attendees should be able to:

The speaker will begin by presenting several clinical cases/case presentations. The cases to be presented will be provided in final proposal. This will be followed by a discussion of the outcome of the case with consideration and implications for current and future clinical and public health practice. The presenter will conclude by discussing preventive steps that can be taken to decrease exposure to environmental hazards and improve patient care.

Case discussed:

The parents of a 6-year old boy with learning and motor delays present to the child’s primary care provider. There have been no recent changes, and vital signs are normal. A developmentally delayed cousin was recently “tested for heavy metals”, so the parents request that these labs be checked for their child as well. In addition to basic labs, heavy metal blood and urine tests are ordered. All results are WNL, except for a random urine arsenic of 93 mcg/gm Cr.

Presented by:

Learning Objectives:

• Describe at least one way that climate impacts the health of children.
• Define climate-smart healthcare.
• Identify two climate-smart approaches that healthcare systems can adopt to reduce contributions to greenhouse gases.
• List two core co-benefits of climate-smart healthcare.

Laura Anderko, PhD, RN
Director, Mid-Atlantic Center for Children's Health & the Environment 
Georgetown University
Region 3 PEHSU

 

 

 

 

 

 

 

Learning Objectives:

• Explain how climate change will impact human health
• Identify specific risks to the health of women of reproductive age and children
• Utilize the “The Impacts of Climate Change on Human Health in the United States: A Scientific Assessment” as a tool for developing educational materials for use by the PEHSUs

Presented By:

At the conclusion of this activity, attendees should be able to:

The presenter will begin by describing the study methodologies used in the journal articles to be discussed. This will be followed by a discussion of the results of the studies under consideration and implications for current clinical and public health practice. The presenter will conclude by discussing preventive steps that can be taken to decrease exposure to endocrine disruptors as evidenced in the journal articles.

Articles discussed:

1. Lungs in a Warming World - Climate Change and Respiratory Health.
Bernstein AS and Rice MB
Chest 2013; 143(5): 1455-1459. 

2. Global Climate Change and Children's Health: Threats and Strategies for Prevention.
Sheffield PE and Landrigan PJ
Environmental Health Perspectives 2011 Mar; 119(3): 291-298

3. Emerging Roles of Health Care Providers to Mitigate Climate Change Impacts: A Perspective from East Harlem, New York
Sheffield PE, Durante KT, Rahona E, and Zarcadoolas C
Health Hum Rights 2015 Jun 16; 16(1):113-121.

Presented By:

Presenter:

Carmen Messerlian, PhD, MSc

Research Scientist

Harvard T.H. Chan School of Public Health

 

 

 

 

 

Learning Objectives:

• Understand how EDCs can contribute to obesity
• Be able to name at least one EDC that may contribute to obesity
• Know the obesogen hypothesis

Sheela Sathyanarayana, MD, MPH
Associate Professor, University of Washington Department of Pediatrics/ Seattle Children’s Research Institute; Attending Physician, Harborview Medical Center, PEHSU; Medical Director, University of Washington Newborn Nursery
Seattle, WA
PEHSU Region 10

 

By the end of this module, participants should be able to:

• Describe the biological effect of endocrine disrupting chemicals and their impact on reproductive and pediatric development.
• Discuss the nature and extent of exposure to endocrine disrupting chemicals among at-risk groups.
• Describe appropriate preventive steps to decrease exposure to endocrine disrupting chemicals.

Learning Objectives:

• Understand the DSHEA regulation and amendments
• Discuss contamination and quality issues with herbal supplements
• Know the herbs most likely to cause Type I allergic reactions
• Describe the liver toxicity from pennyroyal and kava kava
• Describe the CNS toxicity from alpha lipoic acid
• Explain several toxicological problems with Ginkgo biloba

Director

New Mexico Poison & Drug Information Center

PEHSU Region 6

Learning Objectives:

• Understand the descriptive epidemiology of the major neurodegenerative diseases
• Describe the primary mechanistic processes thought to underly Alzheimer’s disease and Parkinson’s disease
• Identify at least one environmental risk factor for Alzheimer’s disease and Parkinson’s disease
• Recognize the long prodromes in neurodegenerative diseases, and how these relate to both causation and potential therapeutic interventions

By the end of this presentation, participants should be able to:

Presenters: Perry Sheffield, MD, MPH, FAAP; Frances Morales Ramos, MPH; and Teresa Herrera, MPH

Learning Objectives:

• Describe the scope and trends in global temperature and regional microclimates.
• Identify the physiologic health effects of extreme heat to different at-risk populations.
• Outline support systems and public health programs regionally and nationally to assist with support in extreme heat events.
• Understand the treatment considerations and evaluation of pregnant and pediatric patients with core temperature elevation.

Learning Objectives:

• List health hazards of volcanic emergencies
• Discuss toxicological hazards of volcanic emergencies
• Discuss personal protective measures
• Discuss patient assessment and management of related toxicological health complaints

Ziad Kazzi, MD
Associate Professor Emergency Medicine and Medical Toxicology
Emory University
PEHSU Region 4

John Balmes, MD
Core Consultant in Occupational and Environmental Medicine
Professor of Medicine, University of California San Francisco
Professor of Environmental Health Sciences, School of Public Health University of California, Berkeley
PEHSU Region 9

Robert J. Geller, MD 
Professor of Pediatrics, Emory University
Medical Director GA Poison Center
PEHSU Region 4

Fuyuen Y. Yip, PhD, MPH
Section Chief (acting), Environmental Health Tracking Section
Lead Poisoning Prevention and Environmental Health Tracking Branch 
National Center for Environmental Health | Centers for Disease Control and Prevention

Kanta Sircar, MPH, PhD, PMP
CDR, US Public Health Service
Epidemiologist, Asthma and Community Health
Division of Environmental Health Science and Practice
National Center for Environmental Health | Centers for Disease Control and Prevention 

 

By the end of this module, participants should be able to:

1. Understand the importance of early environmental health intervention.
2. Identify types of existing early intervention (EI) services at federal and state level.
3. Describe potential impact of synergistic partnerships among existing public health services to amplify the reach of regional PEHSUs while enhancing existing EI services.

Presenter:

Research Scientist

Harvard T.H. Chan School of Public Health

 

 

 

By the end of this module, participants should be able to:

1. Define the chemical family of perfluoroalkyl substances (PFAS) and where they can be found.
2. Outline the scope of potential exposure across the United States. 
3. Describe potential health impacts in children.
4. Discuss implications for clinicians.

• Describe three health behavior change approaches
• Employ techniques in health messaging that will increase likelihood of behavior change
• List examples of health behavior change messages that may decrease exposure to environmental contaminants

Presented By:

Learning Objectives:

• Describe at least one way that climate impacts the health of children.
• Define climate-smart healthcare.
• Identify two climate-smart approaches that healthcare systems can adopt to reduce contributions to greenhouse gases.
• List two core co-benefits of climate-smart healthcare.

Laura Anderko, PhD, RN
Director, Mid-Atlantic Center for Children's Health & the Environment 
Georgetown University
Region 3 PEHSU

 

 

 

 

 

 

Learning Objectives:

• Describe environmental injustice issues related to children living in poverty where they live, learn and play.
• Develop strategies to address environmental injustice issues related to children seen in the pediatric setting.

Jennifer A. Lowry, MD

Learning Objectives

• Define epigenetics in one simple sentence
• Recount three ways that genes can be “turned off”
• Recommend 3 ways for pregnant women to decrease their exposure to environmental toxins

Learning Objectives

• Describe current permissible exposure limits for uranium in drinking water
• Describe the absorption, distribution, and elimination of ingested uranium
• Review the potential effects, if any, of ingested uranium on the renal system
• Review the potential for development of renal or bladder malignancies after long-term exposure to uranium in drinking water
• Describe current testing options and recommendations for patients who may have
• been exposed to uranium in drinking water
• Briefly discuss possible treatment options for uranium exposure

Learning Objectives

• Review health reasons to spend time in Nature
• Learn how DC Park Rx was planned, developed and implemented at a "doctor's office"
• Review recently published data on DC Park Rx
• Summarize next steps for expansion and research of Park Rx

• Learn how chemical in consumer products are regulated in Washington State
• Be able to discuss the benefits and shortcomings of this approach
• Become familiar with the Children’s Safe Product Act and the types of data required to be reported
• Be able to discuss the toxicity and exposure related concerns relevant to prioritizing chemicals in consumer products
• Learn how Toxic Substances Control Act Reform is expected to impact children’s consumer product regulation

Presented By: Elaine Faustman, PhD and Marissa Smith

• Review impact of adverse environmental effects of poverty on children's health and development
• Understand ecology of environmental health disparities in the context of a cycle
• Explore strategies to reduce environmental health disparities and promote children's health and development
• Examine the Break the Cycle Program as a leadership development model to reduce children's environmental health disparities

Presented By:

At the conclusion of this activity, attendees should be able to:

• Increase participants’ knowledge of how development and use of the built environment affects population health
• Describe national statistics on health outcomes and disparities
• Discuss successful community development projects regarding the built environment
• Recognize role of environmental public health advocates in Health Impact Assessment plans 

Presented by:

• Explain how a chemical can act like a hormone
• Recount 3 chemicals with strong evidence for harm in humans
• Recommend 5 ways to personally decrease exposure to environmental toxins

• Provide an overview of a multi-faceted PEHSU response to a community-level exposure.
• Review key principles of pediatric environmental health that were central to PEHSU response.
• Review 3 common clinical inquiries to PEHSUs regarding the community-level exposure and response to local providers:
  • Increased asthma symptoms
  • Request for chemical biomonitoring
  • Management of possible asbestos exposure 

Maida Galvez, MD, MPH, FAAP

Associate Professor in the Departments of Preventive Medicine and Pediatrics; Co-director of the Mount Sinai Transdisciplinary Center for Early Environmental Exposures Community Outreach and Engagement Core

New York, NY
Region 2 PEHSU 

 

 

Lauren Zajac, MD, MPH

Fellow - Pediatrician at Icahn School of Medicine at Mount Sinai 

New York, NY

Region 2 PEHSU

 

 

 

At the conclusion of this activity, attendees should be able to:

The presenter will begin by describing the study methodologies used in the journal articles to be discussed. This will be followed by a discussion of the results of the studies under consideration and implications for current clinical and public health practice. The presenter will conclude by discussing preventive steps that can be taken to decrease exposure to endocrine disruptors as evidenced in the journal articles.

 

Articles discussed:

1. Evidence for hormesis in mutagenicity dose-response relationships.
Calabrese EJ, Stanek EJ 3rd, and Nascarella MA
Mutation Research 2011; 726(2): 91-97

2. An illusion of hormesis in the Ames test: Statistical significance is not equivalent to biological significance.
Zeiger E and Hoffmann GR
Mutation Research 2012; 746(1): 89-93

3. The Frequency of U-Shaped Dose Responses in the Toxicological Literature. 
Calabrese EJ and Baldwin LA 
Toxicological Sciences 2001; 62: 330-338

4. Natural Variability and the Influence of Concurrent Control Values on the Detection and Interpretation of Low-Dose or Weak Endocrine Toxicities.
Ashby J, Tinwell H, Odum J, and Lefevre P

Presented by:

• Identify data available at EPA. 
• Describe the purpose of the Toxics Release Inventory (TRI) Program.
• List potential uses of TRI data.
• Describe limitations of TRI data.
• Identify a tool to access TRI data.

 

Jocelyn Hospital, MS 

Toxicologist

Toxics Release Inventory (TRI) Program

US Environmental Protection Agency (EPA)

Washington, DC

 

 

Kara Koehrn, MEM, BS 

Toxicologist and Data Analyst

Toxics Release Inventory (TRI) Program

US Environmental Protection Agency (EPA)

Washington, DC

 

 

By the end of this webinar, participants should be able to:

 

 

 

 

Webinar Recording (YouTube):

 

 

Learning Objectives:

• Understand what the reference level means to the actions taken in children with elevated blood lead levels
• Describe laboratory tests used to evaluate blood lead levels
• Discuss limitations of various methods of blood lead testing and how it impacts decision making in pediatric practices

Learning Objectives:

• Describe multiple sources that may result in lead poisoning in children.
• Understand the impact that lead has on school readiness
  Provide opportunities to children with lead exposures to optimize the ability to learn

By the end of this webinar, participants should be able to:

Presenter: Alan Woolf, MD, MPH, FAAP, FAACT, FACMT

 

 

By the end of this webinar, participants should be able to:

Presenter: Rose Goldman, MD, MPH

By the end of this module, participants should be able to:

George Sam Wang, MD, FAAP

Assistant Professor of Pediatrics

Section of Emergency Medicine, Medical Toxicology

Department of Pediatrics

University of Colorado Anschutz Medical Campus, Children's Hospital Colorado

Aurora, CO

Region 8 PEHSU

Learning Objectives:

• List signs and symptoms associated with inhalational mercury toxicity
• Discuss challenges in the management of mercury toxicity
• Describe cleanup of household elemental mercury contamination

 

By the end of this module, participants should be able to:

Stephen W. Borron, MD, MS, FACMT

Medical Director, West Texas Regional Poison Center

Director and Chief Medical Consultant, Southwestern Center for Pediatric Environmental Health

Texas Tech University Health Sciences Center

El Paso, TX

Region 6 PEHSU

 

Learning Objectives

At the conclusion of this activity, attendees should be able to:

• To review our understanding of the effects of Zika virus during pregnancy
• To examine available toxicity data for the two insect repellants suggested for personal protection against Zika
  - N, N-diethyl-30methylbenzamide (DEET)
  - Permethrin
• To evaluate epidemiologic data from human pregnancies about the effects of DEET and permethrin during pregnancy

 

Learning Objectives:

 

At the conclusion of this activity, attendees should be able to:

Presented By:

 

Learning Objectives

• Describe what radon is and where it can be found
• Describe some of the known and hypothesized health risks associated with radon exposure
• Know the EPA action level for radon
• Examine some literature investigating whether there is evidence that radon increases the risk of developing lung cancer, leukemia, lymphoma, and CNS malignancies
• Apply this information to discussing radon mitigation with patients and with the community

• Identify the most common cancer risks after a nuclear power plant radionuclide release.
• Describe the importance of latency in the evaluation of cancer risk from environmental sources.
• Identify other non-cancer adverse outcomes in children following radionuclide releases.

Presented By:

• Describe three health behavior change approaches
• Employ techniques in health messaging that will increase likelihood of behavior change
• List examples of health behavior change messages that may decrease exposure to environmental contaminants

Presented By:

Learning Objectives

At the conclusion of this activity, attendees should be able to:

• To review our understanding of the effects of Zika virus during pregnancy
• To examine available toxicity data for the two insect repellants suggested for personal protection against Zika
  - N, N-diethyl-30methylbenzamide (DEET)
  - Permethrin
• To evaluate epidemiologic data from human pregnancies about the effects of DEET and permethrin during pregnancy

 

• Provide an overview of a multi-faceted PEHSU response to a community-level exposure.
• Review key principles of pediatric environmental health that were central to PEHSU response.
• Review 3 common clinical inquiries to PEHSUs regarding the community-level exposure and response to local providers:
  • Increased asthma symptoms
  • Request for chemical biomonitoring
  • Management of possible asbestos exposure 

Maida Galvez, MD, MPH, FAAP

Associate Professor in the Departments of Preventive Medicine and Pediatrics; Co-director of the Mount Sinai Transdisciplinary Center for Early Environmental Exposures Community Outreach and Engagement Core

New York, NY
Region 2 PEHSU 

 

 

 

 

 

Lauren Zajac, MD, MPH

Fellow - Pediatrician at Icahn School of Medicine at Mount Sinai 

New York, NY

Region 2 PEHSU

 

 

 

Partner, D ZINE Partners;

Board Member, U.S. Green Building Council;

Course Instructor, American Society of Heating,

Refrigerating and Air-Conditioning Engineers (ASHRAE),

Member, ASHRAE Epidemic Task Force

 

Laboratory Director,

Toxics Use Reduction Institute,

University of Massachusetts Lowell,

Lowell, MA

 

Associate Professor of Medicine, Harvard Medical School;

Associate Professor of Environmental Health Sciences

Harvard T.H. Chan School of Public Health; 

Director of Faculty Affairs, Department of Medicine

Cambridge Health Alliance

Boston, MA

Alfred N. Romeo, RN, PhD

 

Acting Deputy Director for Safety,

Division of Nonprescription Drugs II,

Office of Nonprescription Drugs,

Center for Drug Evaluation and Research

U.S. Food and Drug Administration

 

Director, Office of Nonprescription Drugs

Office of New Drugs,

Center for Drug Evaluation and Research

U.S. Food and Drug Administration

 

Description

Proper cleaning and disinfection of commonly used devices and surfaces are critical to patient, worker, and public safety during the COVID-19 pandemic. A panel of experts in medical toxicology and environmental health will provide an overview of the safe use and potential adverse health effects from commonly used disinfectants, such as quaternary ammonium compounds, bleach, and hydrogen peroxide.

Learning Objectives:

• Understand the different types of EPA-approved disinfectants of COVID-19
• Describe the acute toxicity of inappropriate use of quaternary ammonium compounds, bleach and hydrogen peroxide
• Discuss the potential health effects of repeated exposure to commonly used disinfectants in schools and healthcare facilities

University of California San Francisco

San Francisco, CA

 

 

 

Ashley Haynes, MD, FACEP

Medical Director, Holland Pathways
Program Physician, Wichita Treatment Center

Addiction Medicine, Sunflower Wellness Retreat

Wichita, KS

 

Charles McKay, MD, FACMT

Past President, American College of Medical Toxicology (ACMT)

Associate Medical Director, Connecticut Poison Control Center

Associate Clinical Professor, University of Connecticut School of Medicine

Farmington, CT

 

 

Description

Proper cleaning and disinfection/sterilization of devices and surfaces are critical to safely providing care to patients in healthcare facilities. This lecture will provide healthcare personnel with a comprehensive overview of when and how sterilants and disinfectants should be used with a focus on critical instruments/devices (i.e., enter sterile body tissue), semi-critical devices (i.e., have contact with mucous membranes or non-intact skin) and non-critical devices and surfaces (i.e., have contact only with intact skin). The following will also be discussed: the ideal disinfectant, monitoring cleaning effectiveness of surfaces, no touch methods of room disinfection, and how to manage a breach in proper disinfection/sterilization of medical instruments.

Learning Objectives:

• Understand the properties of the ideal disinfectant
• Understand the advantages and disadvantage of disinfectants/sterilants for use with critical, semi-critical, and non-critical devices and surfaces
• Understand the Spaulding classification and its use in selecting disinfectants and sterilization methods in healthcare facilities

Learning Objectives:

• Describe why disinfectant use in early care and education settings is of concern
• Describe known toxicities of the major disinfectant classes
• Describe the EPA Safer Choice Program and the Green Cleaning, Sanitizing and Disinfecting Toolkit 

Learning Objectives

• Describe the current state of environmental health considerations in child care
• Identify core components of the Eco-Healthy Child Care® program and related endorsement
• Discuss current initiatives and voluntary state programs available to child care providers

• Make the connection between school indoor environment and student health and academic performance, particularly for asthmatics
• Understand that since there are no standards or guidelines for air quality in schools, acceptable IEQ is based on good practices of design, maintenance and operation of facilities
• Understand the importance of districts having an indoor environmental health program at both the facility and district level, with members that meet routinely to discuss issues, concerns, and to identify best management practices
• Identify the common issues routinely observed in schools and how they may impact indoor environmental conditions and ultimately student health

Webinar Reference Documents:

• EPA's Student Performance Findings from 2012
• Towards Healthy Schools 2015 from Healthy Schools Network
• Robert Wood Johnson Foundation - The Relationship Between School Attendance and Health

Presented By:

• Describe some of the environmental health hazards that occur in child care and school settings
• Describe the roles that federal, state and local agencies may be able to play in preventing or mitigating some of the environmental health hazards that occur in child care and school settings
• Discuss the potential roles of the PEHSUs in assisting schools and agencies in dealing with some of the environmental health hazards that occur in child care and school settings
• Discuss potential improvements in policies and practices for dealing with some of the environmental health hazards that occur in child care and school settings

Jerome Paulson, MD, FAAP